Transdermal therapeutic system for administering rivastigmine or derivatives thereof

US8962014B2 · kind B2 · utility

Assignee

• ACINO AG · DE

Inventors

• Heike Prinz · Unterhaching, DE
• Björn Schurad · Munich, DE
• Thomas Beckert · Darmstadt, DE
• Kristina Linder · Kiefersfelden, DE

Key dates

• Filing date: Dec 14, 2010
• Grant date: Feb 24, 2015
• Expiry date: Jan 6, 2031

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T156/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: